Date published: 2025-9-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

1700011I03Rik Inhibitors

Chemical inhibitors of 1700011I03Rik can target various signaling pathways and enzymatic activities that are likely to be involved in the regulation of this protein's function. Wortmannin and LY294002, both known as phosphoinositide 3-kinases (PI3K) inhibitors, can reduce the activity of 1700011I03Rik by altering phosphoinositide signaling, a key pathway for numerous cellular processes including cell growth and survival. Inhibition of PI3K can disrupt the downstream signaling that may be critical for the proper functioning of 1700011I03Rik. Similarly, rapamycin, an mTOR inhibitor, can decrease the activity of proteins in the mTOR pathway, which includes 1700011I03Rik. The mTOR pathway is integral to cell growth and metabolism, and its inhibition can lead to reduced activity of associated proteins.

Further, Dasatinib and PP2, as inhibitors of Src family kinases, can decrease phosphorylation and consequently the activity of 1700011I03Rik if it is a substrate of Src-mediated phosphorylation. U0126 and PD98059 are inhibitors of MEK1/2, and their role in inhibiting the MEK/ERK pathway can lead to reduced activity of 1700011I03Rik by limiting signals for cell proliferation and differentiation that are typically mediated through this pathway. SP600125 and SB203580, which inhibit JNK and p38 MAPK respectively, can reduce the activity of proteins regulated by these stress-activated signaling pathways, potentially including 1700011I03Rik. Y-27632, a ROCK inhibitor, can disrupt Rho/ROCK pathway signaling, thereby potentially reducing the activity of 1700011I03Rik if it is regulated by this pathway. PD173074, an FGFR inhibitor, can decrease the activity of 1700011I03Rik by inhibiting FGFR signaling, which is crucial for processes such as cell growth and angiogenesis. Lastly, SL327, another MEK1/2 inhibitor, can decrease signaling through the ERK pathway, which in turn can reduce the activity of 1700011I03Rik as part of this pathway's regulatory network. Each of these chemicals, by targeting specific enzymes and pathways, can play a role in inhibiting the function of 1700011I03Rik by disrupting the protein's regulatory signaling mechanisms.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PD173074

219580-11-7sc-202610
sc-202610A
sc-202610B
1 mg
5 mg
50 mg
$46.00
$140.00
$680.00
16
(1)

Inhibits FGFR, which could lead to reduced activity of 1700011I03Rik if it is connected to FGFR signaling.

SL-327

305350-87-2sc-200685
sc-200685A
1 mg
10 mg
$107.00
$332.00
7
(0)

Inhibits MEK1/2, which may result in reduced signaling through the ERK pathway, potentially decreasing the activity of 1700011I03Rik.